Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• 'Dry' and 'wet' cough: how reliable is parental reporting?1 passage
• 'It's not one size fits all': a qualitative study of patients' and healthcare professionals' views of self-management for bronchiectasis.1 passage
• 'Reduced' HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trial.1 passage
• 'Scared to death' dyspnoea from the hospitalised patient's perspective.1 passage
• (untitled)2 passages
• A novel flow cytometric-based method to measure kinase inhibition in sputum from COPD subjects.1 passage
• A study of attitudes, beliefs and organisational barriers related to safe emergency oxygen therapy for patients with COPD (chronic obstructive pulmonary disease) in clinical practice and research.1 passage
• ACE and response to pulmonary rehabilitation in COPD: two observational studies.1 passage
• ARDS following oesophagectomy: a comparison of two trials.1 passage
• ARTP statement on cardiopulmonary exercise testing 2021.1 passage
• ARTP statement on pulmonary function testing 2020.1 passage
• Acceptability of patient reported outcome measures (PROMs) in a cystic fibrosis data registry.1 passage
• Accuracy and cost-effectiveness of dynamic contrast-enhanced CT in the characterisation of solitary pulmonary nodules-the SPUtNIk study.1 passage
• Accuracy of transbronchial biopsy as a rebiopsy method for patients with relapse of advanced non-small-cell lung cancer after systemic chemotherapy.1 passage
• Acute exacerbation of idiopathic pulmonary fibrosis: a 10-year single-centre retrospective study.1 passage
• Acute hypoxaemic respiratory failure in a low-income country: a prospective observational study of hospital prevalence and mortality.1 passage
• Adherence to early pulmonary rehabilitation after COPD exacerbation and risk of hospital readmission: a secondary analysis of the COPD-EXA-REHAB study.1 passage
• Adjuncts for sputum clearance in COPD: clinical consensus versus actual use.1 passage
• Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe-results from the PED-MERMAIDS multicentre case-control study.1 passage
• Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015.1 passage
• Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic.1 passage
• Alcohol drinking and cigarette smoking in relation to risk of active tuberculosis: prospective cohort study.1 passage
• Ambient air pollution and risk of respiratory infection among adults: evidence from the multiethnic study of atherosclerosis (MESA).1 passage
• Ambient air pollution is associated with airway inflammation in older women: a nested cross-sectional analysis.1 passage
• Ambient air pollution, lung function and COPD: cross-sectional analysis from the WHO Study of AGEing and adult health wave 1.1 passage
• Among respiratory symptoms, wheeze associates most strongly with impaired lung function in adults with asthma: a long-term prospective cohort study.1 passage
• An observational study of PM10 and hospital admissions for acute exacerbations of chronic respiratory disease in Tasmania, Australia 1992-2002.1 passage
• Anaemia and iron dysregulation: untapped therapeutic targets in chronic lung disease?1 passage
• Analyses of abdominal adiposity and metabolic syndrome as risk factors for respiratory distress in COVID-19.1 passage
• Analysis of serious adverse events in a paediatric fast breathing pneumonia clinical trial in Malawi.1 passage
• Angiopoietin-like protein 4 and cardiovascular function in COPD.1 passage
• Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis.1 passage
• Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis.1 passage
• Are within-person Numerical Rating Scale (NRS) ratings of breathlessness 'on average' valid in advanced disease for patients and for patients' informal carers?1 passage
• Area under the expiratory flow-volume curve: predicted values by regression and deep learning methods and recommendations for clinical practice.1 passage
• Assessing small airway disease in GLI versus NHANES III based spirometry using area under the expiratory flow-volume curve.1 passage
• Assessing the use of BreatheSmart® mobile technology in adult patients with asthma: a remote observational study.1 passage
• Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells.1 passage
• Assessment of patient-reported outcome measures in pleural interventions.1 passage
• Assistive technologies for home NIV in patients with COPD: feasibility and positive experience with remote-monitoring and volume-assured auto-EPAP NIV mode.1 passage
• Association between influenza vaccination and hospitalisation or all-cause mortality in people with COVID-19: a retrospective cohort study.1 passage
• Association between patterns of leisure time physical activity and asthma control in adult patients.1 passage
• Association between prehospital vitamin D status and incident acute respiratory failure in critically ill patients: a retrospective cohort study.1 passage
• Association between self-reported moderate to vigorous physical activity and the rate of outpatient treated COPD exacerbations: retrospective cohort study.1 passage
• Association of body mass index with morbidity in patients hospitalised with COVID-19.1 passage
• Association of sleep apnoea risk and aortic enlargement in Marfan syndrome.1 passage
• Association of smoking status with outcomes in hospitalised patients with COVID-19.1 passage
• Associations between genetics, medical status, physical exercise and psychological well-being in adults with cystic fibrosis.1 passage
• Asthma control is associated with economic outcomes, work productivity and health-related quality of life in patients with asthma.1 passage
• Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort.1 passage
• Asthma is associated with frailty among community-dwelling adults: the GAZEL cohort.1 passage
• Asthma, rhinitis and eczema symptoms in Quito, Ecuador: a comparative cross-sectional study 16 years after ISAAC.1 passage
• Automatic versus manual oxygen titration using a novel nasal high-flow device in medical inpatients with an acute illness: a randomised controlled trial.1 passage
• BEAM study (Breathing, Education, Awareness, Movement): a randomised controlled feasibility trial of tai chi exercise in patients with COPD.1 passage
• BTS guideline for the investigation and management of malignant pleural mesothelioma.1 passage
• Barriers to identifying occupational asthma among primary healthcare professionals: a qualitative study.1 passage
• Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry.1 passage
• Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients.1 passage
• Breathing-swallowing discoordination is associated with frequent exacerbations of COPD.1 passage
• Breathlessness dimensions association with physical and mental quality of life: the population based VASCOL study of elderly men.1 passage
• British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism.1 passage
• British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).1 passage
• British Thoracic Society Quality Standards for outpatient management of pulmonary embolism.1 passage
• British Thoracic Society Training Standards for Thoracic Ultrasound (TUS).1 passage
• British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together.1 passage
• British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease.1 passage
• British Thoracic Society quality standards for home oxygen use in adults.1 passage
• British Thoracic Society quality standards for the investigation and management of pulmonary nodules.1 passage
• Burden of bacterial upper respiratory tract pathogens in school children of Nepal.1 passage
• Burden of cystic fibrosis in children <12 years of age prior to the introduction of CFTR modulator therapies.1 passage
• CASPA (CArdiac Sarcoidosis in PApworth) improving the diagnosis of cardiac involvement in patients with pulmonary sarcoidosis: protocol for a prospective observational cohort study.1 passage
• CNS imaging studies in cystic fibrosis patients presenting with sudden neurological events.1 passage
• COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months.1 passage
• COPD-Lower Respiratory Tract Infection Visual Analogue Score (c-LRTI-VAS) validation in stable and exacerbated patients with COPD.1 passage
• COVID-19 admission risk tools should include multiethnic age structures, multimorbidity and deprivation metrics for air pollution, household overcrowding, housing quality and adult skills.1 passage
• COVID-19 is associated with distinct myopathic features in the diaphragm of critically ill patients.1 passage
• COVID-19 recovery: benefits of multidisciplinary respiratory rehabilitation.1 passage
• CPAP IMPACT: a protocol for a randomised trial of bubble continuous positive airway pressure versus standard care for high-risk children with severe pneumonia using adaptive design methods.1 passage
• CPAP delivered outside critical care during the second wave of COVID-19: outcomes from a UK respiratory surge unit.1 passage
• CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation.1 passage
• Can categorised values of maximal oxygen uptake discriminate patterns of exercise dysfunction in pectus excavatum: a prospective cohort study?1 passage
• Carcinoid tumours of the lung and the 'PEPPS' approach: evaluation of preoperative bronchoscopic tumour debulking as preparation for subsequent parenchyma-sparing surgery.1 passage
• Cardiopulmonary function in adolescent patients with pectus excavatum or carinatum.1 passage
• Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model.1 passage
• Changes in central venous to arterial carbon dioxide gap (PCO1 passage
• Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience.1 passage
• Characterisation of ICU sleep by a commercially available activity tracker and its agreement with patient-perceived sleep quality.1 passage
• Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda.1 passage
• Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study.1 passage
• Characteristics of new adult users of mepolizumab with asthma in the USA.1 passage
• Characteristics of pulmonary cryptococcosis in patients with rheumatoid arthritis.1 passage
• Chest drain aerosol generation in COVID-19 and emission reduction using a simple anti-viral filter.1 passage
• Chest radiograph reading panel performance in a Bangladesh pneumococcal vaccine effectiveness study.1 passage
• Chest radiograph-based artificial intelligence predictive model for mortality in community-acquired pneumonia.1 passage
• Childhood asthma prevalence: cross-sectional record linkage study comparing parent-reported wheeze with general practitioner-recorded asthma diagnoses from primary care electronic health records in Wales.1 passage
• Chronic airflow limitation and its relation to respiratory symptoms among ever-smokers and never-smokers: a cross-sectional study.1 passage
• Chronic obstructive pulmonary disease associated with biomass fuel use in women: a systematic review and meta-analysis.1 passage
• Ciprofloxacin DPI: a randomised, placebo-controlled, phase IIb efficacy and safety study on cystic fibrosis.1 passage
• Circulating tumour cells and circulating cell-free DNA in patients with lung cancer: a comparison between thoracotomy and video-assisted thoracoscopic surgery.1 passage
• Classification of aerosol-generating procedures: a rapid systematic review.1 passage
• Clinical and financial burden of hospitalised community-acquired pneumonia in patients with selected underlying comorbidities in England.1 passage
• Clinical characteristics and outcomes of adult patients admitted with COVID-19 in East London: a retrospective cohort analysis.1 passage
• Clinical manifestations and outcomes of pulmonary aspergillosis: experience from Pakistan.1 passage
• Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis.1 passage
• Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease.1 passage
• Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary fibrosis and ASyS diagnosed in rheumatology services.1 passage
• Coil embolisation for massive haemoptysis in cystic fibrosis.1 passage
• Combined pulmonary fibrosis and emphysema: effect of pulmonary rehabilitation in comparison with chronic obstructive pulmonary disease.1 passage
• Combining creative writing and narrative analysis to deliver new insights into the impact of pulmonary hypertension.1 passage
• Communication of a mesothelioma diagnosis: developing recommendations to improve the patient experience.1 passage
• Comparative outcomes of inpatients with lung collapse managed by bronchoscopic or conservative means.1 passage
• Comparative study of linear and curvilinear ultrasound probes to assess quadriceps rectus femoris muscle mass in healthy subjects and in patients with chronic respiratory disease.1 passage
• Comparison of foam swabs and toothbrushes as oral hygiene interventions in mechanically ventilated patients: a randomised split mouth study.1 passage
• Comparison of oxygen uptake during cycle ergometry with and without functional electrical stimulation in patients with COPD: protocol for a randomised, single-blind, placebo-controlled, cross-over trial.1 passage
• Comparison of patient-reported outcomes during acute exacerbations of chronic obstructive pulmonary disease.1 passage
• Compliance after switching from CPAP to bilevel for patients with non-compliant OSA: big data analysis.1 passage
• Complications and discomfort after research bronchoscopy in the MicroCOPD study.1 passage
• Complications of indwelling pleural catheter use and their management.1 passage
• Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol.1 passage
• Comprehensive evidence-based review on European antitussives.1 passage
• Concordance of opinions between patients and physicians and their relationship with symptomatic control and future risk in patients with moderate-severe asthma.1 passage
• Coronary artery calcium score may be a novel predictor of COVID-19 prognosis: a retrospective study.1 passage
• Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap.1 passage
• Correlates of obesity-related chronic ventilatory failure.1 passage
• Correlation between biomarkers of exposure, effect and potential harm in the urine of electronic cigarette users.1 passage
• Critical analysis of the utility of initial pleural aspiration in the diagnosis and management of suspected malignant pleural effusion.1 passage
• Cryobiopsy versus open lung biopsy in the diagnosis of interstitial lung disease (COLDICE): protocol of a multicentre study.1 passage
• Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK.1 passage
• Dance for people with chronic breathlessness: a transdisciplinary approach to intervention development.1 passage
• Decreased left ventricular stroke volume is associated with low-grade exercise tolerance in patients with chronic obstructive pulmonary disease.1 passage
• Defining hypoxaemia from pulse oximeter measurements of oxygen saturation in well children at low altitude in Bangladesh: an observational study.1 passage
• Defining the information needs of lung cancer screening participants: a qualitative study.1 passage
• Democratic and ethical problem of lung cancer screening: exclusion of true high-risk populations. Can it be fixed? Yes.1 passage
• Deoxynucleoside therapy for respiratory involvement in adult patients with thymidine kinase 2-deficient myopathy.1 passage
• Depression, anxiety and psychological distress in patients with pulmonary hypertension: a mixed-methods study.1 passage
• Description of the protocol for the PRACTICAL study: a randomised controlled trial of the efficacy and safety of ICS/LABA reliever therapy in asthma.1 passage
• Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease.1 passage
• Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study.1 passage
• Determinants of poor inhaler technique and poor therapy adherence in obstructive lung diseases: a cross-sectional study in community pharmacies.1 passage
• Development in PaCO1 passage
• Development of a conceptual model of childhood asthma to inform asthma prevention policies.1 passage
• Development of a patient-centred, evidence-based and consensus-based discharge care bundle for patients with acute exacerbation of chronic obstructive pulmonary disease.1 passage
• Diagnostic and clinical values of non-cardiac ultrasound in COPD: A systematic review.1 passage
• Differential eligibility of African American and European American lung cancer cases using LDCT screening guidelines.1 passage
• Differentiation of quantitative CT imaging phenotypes in asthma versus COPD.1 passage
• Disease burden and quality of life of patients with chronic cough in Japan: a population-based cross-sectional survey.1 passage
• Disinfection of1 passage
• Dose modification and dose intensity during treatment with pirfenidone: analysis of pooled data from three multinational phase III trials.1 passage
• Downregulation of epithelial sodium channel (ENaC) activity in human airway epithelia after low temperature incubation.1 passage
• Driving performance in patients with chronic obstructive lung disease, interstitial lung disease and healthy controls: a crossover intervention study.1 passage
• ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing.1 passage
• Early NIV is associated with accelerated lung function decline in Duchenne muscular dystrophy treated with glucocorticosteroids.1 passage
• Early conscious prone positioning in patients with COVID-19 receiving continuous positive airway pressure: a retrospective analysis.1 passage
• Early extracellular matrix changes are associated with later development of bronchiolitis obliterans syndrome after lung transplantation.1 passage
• Early identification of severe community-acquired pneumonia: a retrospective observational study.1 passage
• Early respiratory diagnosis: benefits of enhanced lung function assessment.1 passage
• Economic analysis of temperature-controlled laminar airflow (TLA) for the treatment of patients with severe persistent allergic asthma.1 passage
• Economic burden of asthma in Singapore.1 passage
• Education and pneumonia mortality: a trend analysis of its inequalities in Colombian adults.1 passage
• Effect modification by age of the association between obstructive lung diseases, smoking, and COVID-19 severity.1 passage
• Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial.1 passage
• Effect of a machine learning-based severe sepsis prediction algorithm on patient survival and hospital length of stay: a randomised clinical trial.1 passage
• Effect of a pulmonary rehabilitation programme of 8 weeks compared to 12 weeks duration on exercise capacity in people with chronic obstructive pulmonary disease (PuRe Duration): protocol for a randomised controlled trial.1 passage
• Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials.1 passage
• Effect of acute respiratory infections in infancy on pulmonary function test at 3 years of age: a prospective birth cohort study.1 passage
• Effect of anti-podoplanin antibody administration during lipopolysaccharide-induced lung injury in mice.1 passage
• Effect of high-flow nasal therapy during acute aerobic exercise in patients with chronic obstructive pulmonary disease after exacerbation: protocol for a randomised, controlled, cross-over trial.1 passage
• Effect of idiopathic thoracic scoliosis on the tracheobronchial tree.1 passage
• Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD.1 passage
• Effect of vitamin D1 passage
• Effect of β-blockade on lung function, exercise performance and dynamic hyperinflation in people with arterial vascular disease with and without COPD.1 passage
• Effects of body mass index, tobacco smoking, alcohol drinking and solid fuel use on the risk of asthma: Individual Participant Data (IPD) meta-analysis of 175 000 individuals from 51 nationally representative surveys.1 passage
• Effects of different early rehabilitation techniques on haemodynamic and metabolic parameters in sedated patients: protocol for a randomised, single-bind, cross-over trial.1 passage
• Effects of infliximab on lung and circulating natural killer cells, CD56+ T cells and B cells in sarcoidosis.1 passage
• Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: rationale and design of the randomised, double-blind, active-controlled MANDALA study.1 passage
• Efficacy and safety of high flow nasal oxygen for children with bronchiolitis: systematic review and meta-analysis.1 passage
• Efficacy of convalescent plasma for treatment of COVID-19 in Uganda.1 passage
• Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population.1 passage
• Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial.1 passage
• Efficacy of sonographic and biological pleurodesis indicators of malignant pleural effusion (SIMPLE): protocol of a randomised controlled trial.1 passage
• Endobronchial valves for emphysema: an individual patient-level reanalysis of randomised controlled trials.1 passage
• Endotypes identified by cluster analysis in asthmatics and non-asthmatics and their clinical characteristics at follow-up: the case-control EGEA study.1 passage
• Enhanced airway sensory nerve reactivity in non-eosinophilic asthma.1 passage
• Ensuring basic competency in chest tube insertion using a simulated scenario: an international validation study.1 passage
• Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment.1 passage
• Environmental triggers of COPD symptoms: a case cross-over study.1 passage
• Ethnicity and risk of death in patients hospitalised for COVID-19 infection in the UK: an observational cohort study in an urban catchment area.1 passage
• Evaluation of 'care bundles' for patients with chronic obstructive pulmonary disease (COPD): a multisite study in the UK.1 passage
• Evaluation of CPAP mask performance during 3 years of mask usage: time for reconsideration of renewal policies?1 passage
• Evaluation of energy intake by brief-type self-administered diet history questionnaire among male patients with stable/at risk for chronic obstructive pulmonary disease.1 passage
• Evaluation of medication changes following severe COVID-19 infection: a multicentre evaluation.1 passage
• Evaluation of prediagnosis emergency department presentations in patients with active tuberculosis: the role of chest radiography, risk factors and symptoms.1 passage
• Evaluation of the current landscape of respiratory nurse specialists in the UK: planning for the future needs of patients.1 passage
• Examining the possible causal relationship between lung function, COPD and Alzheimer's disease: a Mendelian randomisation study.1 passage
• Exogenous pulmonary surfactant in COVID-19 ARDS. The similarities to neonatal RDS suggest a new scenario for an 'old' strategy.1 passage
• Experiences and views of patients, carers and healthcare professionals on using modems in domiciliary non-invasive ventilation (NIV): a qualitative study.1 passage
• Experiences of nurses caring for respiratory patients during the first wave of the COVID-19 pandemic: an online survey study.1 passage
• Expert artificial intelligence-based natural language processing characterises childhood asthma.1 passage
• Exploration of therapists' views of practice within critical care.1 passage
• Exploratory cost-effectiveness model of electromagnetic navigation bronchoscopy (ENB) compared with CT-guided biopsy (TTNA) for diagnosis of malignant indeterminate peripheral pulmonary nodules.1 passage
• Exploratory study into the effect of abdominal mass loading on airways resistance and ventilatory failure.1 passage
• Extracorporeal CO1 passage
• FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease.1 passage
• Face mask sampling reveals antimicrobial resistance genes in exhaled aerosols from patients with chronic obstructive pulmonary disease and healthy volunteers.1 passage
• Factors affecting the use of neurally adjusted ventilatory assist in the adult critical care unit: a clinician survey.1 passage
• Factors associated with relapse in adult patients discharged from the emergency department following acute asthma: a systematic review.1 passage
• Fast decliner phenotype of chronic obstructive pulmonary disease (COPD): applying machine learning for predicting lung function loss.1 passage
• Feasibility and acceptability of a community pharmacy referral service for suspected lung cancer symptoms.1 passage
• Feasibility and acceptability of introducing advance care planning on a thoracic medicine inpatient ward: an exploratory mixed method study.1 passage
• Feasibility of an online platform delivery of pulmonary rehabilitation for individuals with chronic respiratory disease.1 passage
• Feasibility of cardiopulmonary exercise testing in interstitial lung disease: the PETFIB study.1 passage
• Feasibility of completing Multidimensional Dyspnea Profile and Dyspnea-12 over the telephone in patients with oxygen-dependent disease.1 passage
• Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study): a double-blind, parallel-arm randomised feasibility trial.1 passage
• Feasibility study of in vitro drug sensitivity assay of advanced non-small cell lung adenocarcinomas.1 passage
• Fever is associated with higher morbidity and clot burden in patients with acute pulmonary embolism.1 passage
• Fine crackles on chest auscultation in the early diagnosis of idiopathic pulmonary fibrosis: a prospective cohort study.1 passage
• First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative.1 passage
• Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities?1 passage
• Gait speed is associated with death or readmission among patients surviving acute hypercapnic respiratory failure.1 passage
• Geographically linked risk factors for enrolment into a fast breathing child pneumonia trial in Lilongwe, Malawi: an Innovative Treatments in Pneumonia (ITIP) secondary analysis.1 passage
• Global Asthma Network Phase I study in Mexico: prevalence of asthma symptoms, risk factors and altitude associations-a cross-sectional study.1 passage
• Guidelines on the management of acute respiratory distress syndrome.1 passage
• High prevalence of exercise-induced stridor during Parkrun: a cross-sectional field-based evaluation.1 passage
• High-flow nasal cannula therapy for initial oxygen administration in acute hypercapnic respiratory failure: study protocol of randomised controlled unblinded trial.1 passage
• High-flow nasal cannula therapy in a predominantly African American population with COVID-19 associated acute respiratory failure.1 passage
• Higher BMI is associated with higher expiratory airflow normalised for lung volume (FEF25-75/FVC) in COPD.1 passage
• Higher serum vitamin D levels are associated with decreased odds of obstructive lung disease in the general population: an NHANES analysis (2007-2008 to 2009-2010).1 passage
• Home-based pulmonary rehabilitation early after hospitalisation in COPD (early HomeBase): protocol for a randomised controlled trial.1 passage
• How can we relieve gastrointestinal symptoms in people with cystic fibrosis? An international qualitative survey.1 passage
• Hyperlipidaemia and mortality among patients hospitalised with pneumonia: retrospective cohort and propensity score matched study.1 passage
• ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF.1 passage
• Identifying causation in hypersensitivity pneumonitis: a British perspective.1 passage
• Image enhancement technology in bronchoscopy: a prospective multicentre study in lung cancer.1 passage
• Immediate effects of systemic administration of normal and high O1 passage
• Impact of blood group on survival following critical illness: a single-centre retrospective observational study.1 passage
• Impact of corticosteroids in hospitalised COVID-19 patients.1 passage
• Impact of dietary nitrate supplementation on exercise capacity and cardiovascular parameters in chronic respiratory disease: a systematic review and meta-analysis.1 passage
• Impact of surgical maxillomandibular advancement upon pharyngeal airway volume and the apnoea-hypopnoea index in the treatment of obstructive sleep apnoea: systematic review and meta-analysis.1 passage
• Impact of the introduction of a universal childhood influenza vaccination programme on influenza-related admissions to paediatric intensive care units in England.1 passage
• Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial).1 passage
• Improved COVID-19 outcomes in a large non-invasive respiratory support cohort despite emergence of the alpha variant.1 passage
• Improved survival following ward-based non-invasive pressure support for severe hypoxia in a cohort of frail patients with COVID-19: retrospective analysis from a UK teaching hospital.1 passage
• Improving the early identification of COVID-19 pneumonia: a narrative review.1 passage
• In vitro evaluation of disposable transport ventilators with combination aerosol therapy.1 passage
• Incidence of bleeding in patients on different anticoagulants and antiplatelet therapies undergoing thoracentesis.1 passage
• Incidence of tuberculosis and the influence of surveillance strategy on tuberculosis case-finding and all-cause mortality: a cluster randomised trial in Indian neonates vaccinated with BCG.1 passage
• Inconsistent calculation methodology for the eucapnic voluntary hyperpnoea test affects the diagnosis of exercise-induced bronchoconstriction.1 passage
• Increase in recruitment upon integration of trial into a clinical care pathway: an observational study.1 passage
• Indwelling pleural catheters for non-malignant pleural effusions: report on a single centre's 10 years of experience.1 passage
• Influence of HIV status on the management of acute asthma exacerbations.1 passage
• Influence of age on real-life effects of doxycycline for acute exacerbations among COPD outpatients: a population-based cohort study.1 passage
• Influence of asthma and obesity on respiratory symptoms, work ability and lung function: findings from a cross-sectional Norwegian population study.1 passage
• Influence of observer preferences and auscultatory skill on the choice of terms to describe lung sounds: a survey of staff physicians, residents and medical students.1 passage
• Influence of weight status in the response to Step-2 maintenance therapies in children with asthma.1 passage
• Influenza vaccination for NHS staff: attitudes and uptake.1 passage
• Inhaled corticosteroid dose is associated with1 passage
• Initial experience with transbronchial cryoablation as a novel local treatment for malignant peripheral lung lesions.1 passage
• Initiation, scale-up and outcomes of the Cambodian National MDR-TB programme 2006-2016: hospital and community-based treatment through an NGO-NTP partnership.1 passage
• Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence.1 passage
• Inspiratory crackles-early and late-revisited: identifying COPD by crackle characteristics.1 passage
• Integrated care for resected early stage lung cancer: innovations and exploring patient needs.1 passage
• Integrated diagnostic pathway for patients referred with suspected OSA: a model for collaboration across the primary-secondary care interface.1 passage
• Integrating patients with chronic respiratory disease and heart failure into a combined breathlessness rehabilitation programme: a service redesign and pilot evaluation.1 passage
• International perception of lung sounds: a comparison of classification across some European borders.1 passage
• Interventions to standardise hospital care at presentation, admission or discharge or to reduce unnecessary admissions or readmissions for patients with acute exacerbation of chronic obstructive pulmonary disease: a scoping review.1 passage
• Intestinal current measurement and nasal potential difference to make a diagnosis of cases with inconclusive1 passage
• Intravenous iron and chronic obstructive pulmonary disease: a randomised controlled trial.1 passage
• Investigating outcome measures for assessing airway clearance techniques in adults with cystic fibrosis: protocol of a single-centre randomised controlled crossover trial.1 passage
• Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial.1 passage
• Is childhood wheeze and asthma in Latin America associated with poor hygiene and infection? A systematic review.1 passage
• Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated COVID-19 CPAP service.1 passage
• Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?1 passage
• Is there an association between subjective sleep quality and daily delirium occurrence in critically ill adults? A post hoc analysis of a randomised controlled trial.1 passage
• LDCT lung cancer screening in populations at different risk for lung cancer.1 passage
• Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease.1 passage
• Last-resort strategies during mask shortages: optimal design features of cloth masks and decontamination of disposable masks during the COVID-19 pandemic.1 passage
• Lifestyle and comorbid conditions as risk factors for community-acquired pneumonia in outpatient adults (NEUMO-ES-RISK project).1 passage
• Lifestyle factors and experience of respiratory alarm symptoms in the general population.1 passage
• Listening panel agreement and characteristics of lung sounds digitally recorded from children aged 1-59 months enrolled in the Pneumonia Etiology Research for Child Health (PERCH) case-control study.1 passage
• London ambulance source data on choking incidence for the calendar year 2016: an observational study.1 passage
• Long-term effect of azithromycin in bronchiolitis obliterans syndrome.1 passage
• Long-term outcomes following severe COVID-19 infection: a propensity matched cohort study.1 passage
• Long-term outcomes of patients with pulmonary arteriovenous malformations considered for lung transplantation, compared with similarly hypoxaemic cohorts.1 passage
• Longevity of pulmonary rehabilitation benefit for chronic obstructive pulmonary disease-health care utilisation in the subsequent 2 years.1 passage
• Longitudinal change in quality of life following hospitalisation for acute exacerbations of COPD.1 passage
• Low lung function, sudden cardiac death and non-fatal coronary events in the general population.1 passage
• Low utilisation of bronchoscopy to assess COVID-19 respiratory infection: a multicenter experience.1 passage
• Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study.1 passage
• Lung transplant after 6 months on ECMO support for SARS-CoV-2-induced ARDS complicated by severe antibody-mediated rejection.1 passage
• Lung ultrasound volume sweep imaging for respiratory illness: a new horizon in expanding imaging access.1 passage
• Lung volumes identify an at-risk group in persons with prolonged secondhand tobacco smoke exposure but without overt airflow obstruction.1 passage
• Lymphangiogenic factors are associated with the severity of hypersensitivity pneumonitis.1 passage
• Maintaining quality of life in patients with chronic obstructive pulmonary disease (COPD) by extending the maintenance phase of community-based pulmonary rehabilitation: protocol for a randomised controlled trial (ComEx3 Study).1 passage
• Management of tracheostomies in the intensive care unit: a scoping review.1 passage
• Managing complex respiratory patients in the community: an evaluation of a pilot integrated respiratory care service.1 passage
• Manual ventilation and open suction procedures contribute to negative pressures in a mechanical lung model.1 passage
• Maternal iron status during pregnancy and respiratory and atopic outcomes in the offspring: a Mendelian randomisation study.1 passage
• Measurement of breathing in patients with post-COVID-19 using structured light plethysmography (SLP).1 passage
• Measuring urbanicity as a risk factor for childhood wheeze in a transitional area of coastal ecuador: a cross-sectional analysis.1 passage
• MesoTRAP: a feasibility study that includes a pilot clinical trial comparing video-assisted thoracoscopic partial pleurectomy decortication with indwelling pleural catheter in patients with trapped lung due to malignant pleural mesothelioma designed to address recruitment and randomisation uncertainties and sample size requirements for a phase III trial.1 passage
• Metabolomics of World Trade Center-Lung Injury: a machine learning approach.1 passage
• Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy.1 passage
• Minimal clinically important difference for chest discomfort in patients undergoing pleural interventions.1 passage
• Molecular epidemiological study of enterovirus D68 in hospitalised children in Hong Kong in 2014-2015 and their complete coding sequences.1 passage
• Monitoring tuberculosis contact tracing outcomes in Western Sydney, Australia.1 passage
• Monocyte and neutrophil levels are potentially linked to progression to IPF for patients with indeterminate UIP CT pattern.1 passage
• Moving singing for lung health online in response to COVID-19: experience from a randomised controlled trial.1 passage
• Multicentre pilot randomised clinical trial of early in-bed cycle ergometry with ventilated patients.1 passage
• Multicentre pilot study evaluation of lung ultrasound for the management of paediatric pneumonia in low-resource settings: a study protocol.1 passage
• Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic1 passage
• Narrative review of primary care point-of-care testing (POCT) and antibacterial use in respiratory tract infection (RTI).1 passage
• Nasopharyngeal density of respiratory viruses in childhood pneumonia in a highly vaccinated setting: findings from a case-control study.1 passage
• New method to measure interbreath intervals in infants for the assessment of apnoea and respiration.1 passage
• No association between DNA methylation and COPD in never and current smokers.1 passage
• Non-invasive testing for liver pathology in alpha-1 antitrypsin deficiency.1 passage
• Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician survey.1 passage
• Novel electronic adherence monitoring devices in children with asthma: a mixed-methods study.1 passage
• Novel measure of lung function for assessing disease activity in asthma.1 passage
• Novel method to select meaningful outcomes for evaluation in clinical trials.1 passage
• Novel non-invasive particles in exhaled air method to explore the lining fluid of small airways-a European population-based cohort study.1 passage
• Novel pharmacist-led intervention secures the minimally important difference (MID) in Asthma Control Test (ACT) score: better outcomes for patients and the healthcare provider.1 passage
• Objective measurement of lung volume recruitment therapy: laboratory and clinical validation.1 passage
• One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies.1 passage
• Optimal resection rate for lung cancer in the UK: how high should we go?1 passage
• Oral nutrition supplements and between-meal snacks for nutrition therapy in patients with COPD identified as at nutritional risk: a randomised feasibility trial.1 passage
• Patient experience of COPD care: outcomes from the British Lung Foundation Patient Passport.1 passage
• Patient symptoms and experience following COVID-19: results from a UK-wide survey.1 passage
• Patient-reported outcome measures in community-acquired pneumonia: a systematic review of application and content validity.1 passage
• Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis.1 passage
• Patients' practices and experiences of using nebuliser therapy in the management of COPD at home.1 passage
• Patterns and management of chronic obstructive pulmonary disease in urban and rural China: a community-based survey of 25 000 adults across 10 regions.1 passage
• Perceptions of medical students towards antibiotic prescribing for upper respiratory tract infections in Saudi Arabia.1 passage
• Performance monitoring of EBUS for the staging and diagnosis of lung cancer: auditing the Greater Manchester EBUS service against new national standards.1 passage
• Performance of popular pulse oximeters compared with simultaneous arterial oxygen saturation or clinical-grade pulse oximetry: a cross-sectional validation study in intensive care patients.1 passage
• Phenotypic characteristics and asthma severity in an East African cohort of adults and adolescents with asthma: findings from the African severe asthma project.1 passage
• Physiological demands of singing for lung health compared with treadmill walking.1 passage
• Physiological tests of small airways function in diagnosing asthma: a systematic review.1 passage
• Pilot study: an intensive care unit sleep promotion protocol.1 passage
• Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial.1 passage
• Plasma sphingolipids in HIV-associated chronic obstructive pulmonary disease.1 passage
• Pneumomediastinum in marijuana users: a retrospective review of 14 cases.1 passage
• Poor cough flow in acute stroke patients is associated with reduced functional residual capacity and low cough inspired volume.1 passage
• Portable negative pressure environment to protect staff during aerosol-generating procedures in patients with COVID-19.1 passage
• Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals.1 passage
• Post-tuberculous fibrosing mediastinitis: a review of the literature.1 passage
• Potential for integrating yoga within pulmonary rehabilitation and recommendations of reporting framework.1 passage
• Pre-EDIT: protocol for a randomised feasibility trial of elastance-directed intrapleural catheter or talc pleurodesis (EDIT) in malignant pleural effusion.1 passage
• Precise navigation surgery of tumours in the lung in mouse models enabled by in situ fluorescence labelling with a killer-reporter adenovirus.1 passage
• Predicting risk of COPD in primary care: development and validation of a clinical risk score.1 passage
• Predicting survival in malignant pleural mesothelioma using routine clinical and laboratory characteristics.1 passage
• Predictive factors for sleep apnoea in patients on opioids for chronic pain.1 passage
• Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes.1 passage
• Predictors of 30-day readmission following hospitalisation with community-acquired pneumonia.1 passage
• Predictors of postoperative acute exacerbation of interstitial lung disease: a case-control study.1 passage
• Presentation and healthcare delays among people with tuberculosis in London, and the impact on treatment outcome.1 passage
• Prevalence and outcome of central airway obstruction in patients with lung cancer.1 passage
• Prevalence and significance of pulmonary disease on lung ultrasonography in outpatients with SARS-CoV-2 infection.1 passage
• Prevalence of gastrointestinal dysmotility and complications detected by abdominal plain films after lung transplantation: a single-centre cohort study.1 passage
• Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.1 passage
• Prognostic indicators for in-hospital mortality in COPD with acute exacerbation in Thailand: a retrospective cohort study.1 passage
• Prognostic significance of serum cytokines during acute exacerbation of idiopathic interstitial pneumonias treated with thrombomodulin.1 passage
• Progression of the Radiologic Severity Index is associated with increased mortality and healthcare resource utilisation in acute leukaemia patients with pneumonia.1 passage
• Promoting early diagnosis and recovering from the COVID-19 pandemic in lung cancer through public awareness campaigns: learning from patient and public insight work.1 passage
• Prompt recognition of infectious pulmonary tuberculosis is critical to achieving elimination goals: a retrospective cohort study.1 passage
• Protocol for the Stather Canadian Outcomes Registry for Chest ProcedurEs (SCOPE).1 passage
• Providing safe and effective pleural medicine services in the UK: an aspirational statement from UK pleural physicians.1 passage
• Psychological burden associated with worse clinical outcomes in sarcoidosis.1 passage
• Psychometric properties of the St George's Respiratory Questionnaire in patients with idiopathic pulmonary fibrosis: insights from the INPULSIS trials.1 passage
• Pulmonary artery perfusion versus no pulmonary perfusion during cardiopulmonary bypass in patients with COPD: a randomised clinical trial.1 passage
• Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine and time to initiation of enzyme replacement therapy.1 passage
• Pulmonary passport: a service evaluation study of a standardised web-based procedure logbook to aid specialist respiratory training and appraisal.1 passage
• Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation.1 passage
• Randomised Ambulatory Management of Primary Pneumothorax (RAMPP): protocol of an open-label, randomised controlled trial.1 passage
• Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations.1 passage
• Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease.1 passage
• Randomised controlled trial to compare the diagnostic yield of positron emission tomography CT (PET-CT) TARGETed pleural biopsy versus CT-guided pleural biopsy in suspected pleural malignancy (TARGET trial).1 passage
• Randomised cross-over trial evaluating the short-term effects of non-invasive ventilation as an adjunct to airway clearance techniques in adults with cystic fibrosis.1 passage
• Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol.1 passage
• Randomised trial of first-line bronchial artery embolisation for non-severe haemoptysis of mild abundance.1 passage
• Rat model of smoke inhalation-induced acute lung injury.1 passage
• Rationale for and design of the Idiopathic Pulmonary Fibrosis-PRospective Outcomes (IPF-PRO) registry.1 passage
• Rationale for azithromycin in COVID-19: an overview of existing evidence.1 passage
• Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2).1 passage
• Readily accessible CT scoring method to quantify fibrosis in IPF.1 passage
• Real-world retrospective observational study exploring the effectiveness and safety of antifibrotics in idiopathic pulmonary fibrosis.1 passage
• Real-world use of rescue inhaler sensors, electronic symptom questionnaires and physical activity monitors in COPD.1 passage
• Reasons for Accident and Emergency department attendance by people with chronic obstructive pulmonary disease or heart failure: recipients and providers' perspectives. An exploratory study.1 passage
• Recommendations following a modified UK-Delphi consensus study on best practice for referral and management of severe asthma.1 passage
• Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries.1 passage
• Reducing hospital admissions for COPD: perspectives following the Christchurch Earthquake.1 passage
• Reflexive thematic analysis exploring stakeholder experiences of virtual pulmonary rehabilitation (VIPAR).1 passage
• Relating Experienced To Recalled breathlessness Observational (RETRO) study: a prospective study using a mobile phone application.1 passage
• Relationship between body composition, exercise capacity and health-related quality of life in idiopathic pulmonary fibrosis.1 passage
• Relationship of1 passage
• Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies.1 passage
• Reliable EGFR mutation testing in ultrasound-guided supraclavicular lymph node fine-needle aspirates: a cohort study with diagnostic performance analysis.1 passage
• Remote-Management of COPD: Evaluating the Implementation of Digital Innovation to Enable Routine Care (RECEIVER): the protocol for a feasibility and service adoption observational cohort study.1 passage
• Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease.1 passage
• Respiratory symptoms are more common among short sleepers independent of obesity.1 passage
• Respiratory tract infections (RTIs) in primary care: narrative review of C reactive protein (CRP) point-of-care testing (POCT) and antibacterial use in patients who present with symptoms of RTI.1 passage
• Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure.1 passage
• Risk and temporal order of disease diagnosis of comorbidities in patients with COPD: a population health perspective.1 passage
• Risk factors of mortality among patients hospitalised with COVID-19 in a critical care or hospital care unit: analysis of the French national medicoadministrative database.1 passage
• Rural to urban migration is associated with increased prevalence of childhood wheeze in a Latin-American city.1 passage
• SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study.1 passage
• SARS-CoV-2 organising pneumonia: 'Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?'1 passage
• Safety and efficacy of ambulatory management of secondary spontaneous pneumothorax: a case series.1 passage
• Safety and efficacy of catheter directed thrombolysis (CDT) in elderly with pulmonary embolism (PE).1 passage
• Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials.1 passage
• Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials.1 passage
• Sarcoidosis in the UK: insights from British Thoracic Society registry data.1 passage
• Seasonal variability of lung function and Asthma Quality of Life Questionnaire Scores in adults with uncontrolled asthma.1 passage
• Secondary erythrocytosis following drugs used in rifampicin/multidrug-resistant tuberculosis: a retrospective cohort study.1 passage
• Self-reported symptoms of chronic cough and breathlessness in working-age men in the city of Izhevsk, Russia: associations with cardiovascular disease risk factors and comorbidities.1 passage
• Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response.1 passage
• Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial.1 passage
• Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts.1 passage
• Serum levels of immunoglobulins and severity of community-acquired pneumonia.1 passage
• Sex and intimacy in people with severe asthma: a qualitative study.1 passage
• Sex-specific incidence of asthma, rhinitis and respiratory multimorbidity before and after puberty onset: individual participant meta-analysis of five birth cohorts collaborating in MeDALL.1 passage
• Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence.1 passage
• Sleep apnoea is a risk factor for severe COVID-19.1 passage
• Smoking and lung function among adults with newly onset asthma.1 passage
• Sociodemographic factors associated with time to discharge for hospitalised patients with asthma and asthma exacerbation using the Ghana Health Service District Information Management System 2 (DHIMS-2) database, 2012-2017.1 passage
• Specialist emergency care and COPD outcomes.1 passage
• Specialist palliative care, psychology, interstitial lung disease (ILD) multidisciplinary team meeting: a novel model to address palliative care needs.1 passage
• Specialist pneumonia intervention nurse service improves pneumonia care and outcome.1 passage
• Specialty COPD care during COVID-19: patient and clinician perspectives on remote delivery.1 passage
• Sputum colour can identify patients with neutrophilic inflammation in asthma.1 passage
• Stability in eosinophil categorisation during subsequent severe exacerbations of COPD.1 passage
• Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study.1 passage
• Step 4: stick or twist? A review of asthma therapy.1 passage
• Study investigating the generalisability of a COPD trial based in primary care (Salford Lung Study) and the presence of a Hawthorne effect.1 passage
• Successful awake proning is associated with improved clinical outcomes in patients with COVID-19: single-centre high-dependency unit experience.1 passage
• Sudden death in individuals with obstructive sleep apnoea: a systematic review and meta-analysis.1 passage
• Survival models to support shared decision-making about advance care planning for people with advanced stage cystic fibrosis.1 passage
• Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors.1 passage
• Symptom severity and its effect on health-related quality of life over time in patients with pulmonary hypertension: a multisite longitudinal cohort study.1 passage
• Symptomatic, biochemical and radiographic recovery in patients with COVID-19.1 passage
• Systematic identification and referral of smokers attending HIV ambulatory care highlights the failure of current service provision in an at-risk population.1 passage
• Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review.1 passage
• Systemic inflammation induced by exacerbation of COPD or pneumonia in patients with COPD induces cardiac troponin elevation.1 passage
• TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis.1 passage
• Temporal analysis of determinants for respiratory emergency department visits in a large German hospital.1 passage
• Ten-year prediction model for post-bronchodilator airflow obstruction and early detection of COPD: development and validation in two middle-aged population-based cohorts.1 passage
• The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS): description of the protocol for a multicentre prospective observational cohort study identifying biomarkers of progressive fibrotic lung disease.1 passage
• The King's Brief Interstitial Lung Disease (KBILD) questionnaire: an updated minimal clinically important difference.1 passage
• The effect of tiotropium/olodaterol versus fluticasone propionate/salmeterol on left ventricular filling and lung hyperinflation in patients with COPD.1 passage
• The effects of pleural fluid drainage on respiratory function in mechanically ventilated patients after cardiac surgery.1 passage
• The effects of sildenafil on ciliary beat frequency in patients with pulmonary non-tuberculous mycobacteria disease: phase I/II trial.1 passage
• The physiology of singing and implications for 'Singing for Lung Health' as a therapy for individuals with chronic obstructive pulmonary disease.1 passage
• Three-month validation of a turbuhaler electronic monitoring device: implications for asthma clinical trial use.1 passage
• Time to NIV and mortality in AECOPD hospital admissions: an observational study into real world insights from National COPD Audits.1 passage
• Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry.1 passage
• Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study.1 passage
• Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848.1 passage
• Training opportunities in thoracic ultrasound for respiratory trainees: are current guidelines practical?1 passage
• Trajectory of inhaled cadmium ultrafine particles in smokers.1 passage
• Transitions and touchpoints in idiopathic pulmonary fibrosis.1 passage
• Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre study.1 passage
• Trending peripheral venous PCO1 passage
• Trends in hospital admissions and mortality rates for asthma in Ecuador: a joinpoint regression analysis of data from 2000 to 2018.1 passage
• Two chair test: a substitute of 6 min walk test appear cardiopulmonary reserve specific.1 passage
• Typical within and between person variability in non-invasive ventilator derived variables among clinically stable, long-term users.1 passage
• Ultrasonographic assessment of diaphragmatic contraction and relaxation properties: correlations of diaphragmatic displacement with oesophageal and transdiaphragmatic pressure.1 passage
• Underlying contributing conditions to breathlessness among middle-aged individuals in the general population: a cross-sectional study.1 passage
• Understanding changes in dyspnoea perception in obstructive lung disease after mindfulness training.1 passage
• Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID).1 passage
• Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer Database.1 passage
• Use of bubble continuous positive airway pressure (bCPAP) in the management of critically ill children in a Malawian paediatric unit: an observational study.1 passage
• Use of peripheral neutrophil to lymphocyte ratio and peripheral monocyte levels to predict survival in fibrotic hypersensitivity pneumonitis (fHP): a multicentre retrospective cohort study.1 passage
• Use, utility and methods of telehealth for patients with COPD in England and Wales: a healthcare provider survey.1 passage
• Using and implementing care bundles for patients with acute admission for COPD: qualitative study of healthcare professionals' experience in four hospitals in England.1 passage
• Using domiciliary non-invasive ventilator data downloads to inform clinical decision-making to optimise ventilation delivery and patient compliance.1 passage
• Utility and validity of dynamic chest radiography in cystic fibrosis (dynamic CF): an observational, non-controlled, non-randomised, single-centre, prospective study.1 passage
• Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA.1 passage
• Utility of radial endobronchial ultrasonography combined with transbronchial lung cryobiopsy in patients with diffuse parenchymal lung diseases: a multicentre prospective study.1 passage
• Validation of a metered dose inhaler electronic monitoring device: implications for asthma clinical trial use.1 passage
• Validation of the STOP-Bang questionnaire as a screening tool for obstructive sleep apnoea in patients with cardiovascular risk factors: a systematic review and meta-analysis.1 passage
• Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease.1 passage
• Variation in treatment preferences of pulmonary exacerbations among Australian and New Zealand cystic fibrosis physicians.1 passage
• Venous thromboembolism in patients with COVID-19 and correlation with D-dimers: a single-centre experience.1 passage
• Veterans Specific Activity Questionnaire (VSAQ): a new and efficient method of assessing exercise capacity in patients with pulmonary arteriovenous malformations.1 passage
• Vimentin as a target for the treatment of COVID-19.1 passage
• Visual rating assessment of cerebral atrophy and its relationship with cognitive function in chronic obstructive pulmonary disease.1 passage
• Web-based survey to evaluate the prevalence of chronic and subacute cough and patient characteristics in Japan.1 passage
• What are the pros and cons of electronically monitoring inhaler use in asthma? A multistakeholder perspective.1 passage
• What effective ways of motivation, support and technologies help people with cystic fibrosis improve and sustain adherence to treatment?1 passage
• Which behaviour change techniques are most effective in improving healthcare utilisation in COPD self-management programmes? A protocol for a systematic review.1 passage
• Working accuracy of pulse oximetry in COVID-19 patients stepping down from intensive care: a clinical evaluation.1 passage
• Yield of EBUS-TBNA for the diagnosis of sarcoidosis: impact of operator and cytopathologist experience.1 passage